Is the single parathyroid adenoma causing primary hyperparathyroidism with hypercalcemia and elevated intact PTH cancerous?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is a Parathyroid Adenoma Cancerous?

No, a single parathyroid adenoma causing primary hyperparathyroidism is not cancerous—it is a benign tumor. Parathyroid adenomas account for 80-85% of primary hyperparathyroidism cases and are benign neoplasms, not malignancies. 1, 2

Benign Nature of Parathyroid Adenomas

  • Parathyroid adenomas are benign tumors that cause excessive and abnormally regulated secretion of parathyroid hormone, leading to hypercalcemia and the metabolic disturbances you're observing. 2

  • Single-gland parathyroid adenomas are the typical presentation in sporadic primary hyperparathyroidism, representing the vast majority of cases in patients without genetic syndromes. 3

  • After surgical removal of a parathyroid adenoma, serum calcium levels return to normal immediately, confirming the benign but hyperfunctioning nature of these lesions. 1, 4, 2

When to Consider Parathyroid Carcinoma

While parathyroid adenomas are benign, you should be aware of the rare entity of parathyroid carcinoma, which occurs in approximately 15% of patients with CDC73-related (Hyperparathyroid-Jaw Tumor) syndrome. 3

Red Flags for Malignancy:

  • Loss of nuclear parafibromin staining on immunohistochemistry of any parathyroid neoplasm should prompt consideration of germline CDC73 analysis and raises concern for carcinoma. 3

  • Clinical features suggesting carcinoma include extremely high PTH levels (often >5-10 times normal), palpable neck mass, vocal cord paralysis, or severe hypercalcemia (>14 mg/dL). 3

  • Parafibromin immunohistochemistry should be performed on all parathyroid neoplasms in young patients, as it may help distinguish adenomatous from carcinomatous nodules. 3

Genetic Syndromes to Consider

In the context of a young patient or family history, consider:

  • CDC73-related syndrome can present with parathyroid adenomas as young as age 7 years, with approximately 15% developing parathyroid carcinoma. 3

  • MEN4 syndrome (CDKN1B variants) typically presents later (youngest reported at age 30) and is associated with parathyroid adenomas, not carcinomas. 3

  • MEN1 syndrome causes parathyroid adenomas or hyperplasia, not carcinomas. 3

Clinical Management Implications

  • Surgical excision (parathyroidectomy) is the definitive treatment for symptomatic primary hyperparathyroidism due to parathyroid adenoma, and it is curative for this benign condition. 5

  • Surgery is indicated even when asymptomatic given the potential negative effects of long-term hypercalcemia on bones, kidneys, and cardiovascular system. 5

  • Biopsy of suspicious neck lesions is discouraged in patients with suspected parathyroid disease due to risk of seeding and capsular disruption. 3

Common Pitfall

The most important pitfall is assuming all hypercalcemia in cancer patients is due to malignancy-associated hypercalcemia. In fact, patients with known malignancies can have concomitant primary hyperparathyroidism from benign parathyroid adenomas—18 such cases were documented with various cancers (colon, breast, lymphoma, thyroid), and all were cured by parathyroidectomy. 1

References

Research

Malignancy and concomitant primary hyperparathyroidism.

Journal of surgical oncology, 1988

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Parathyroid Adenoma and Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the treatment plan for a patient with asymptomatic hypercalcemia and elevated intact parathyroid hormone (iPTH) level, confirmed parathyroid adenoma on sestamibi scan?
What is the most appropriate next step in management for a patient with fatigue, recurrent ureteric (urinary tract) stones, bone pain, hypercalcemia (elevated calcium levels), and a 2cm parathyroid adenoma?
What is the most appropriate next step in management for a patient with primary hyperparathyroidism, presenting with fatigue, recurrent ureteric stones, bone pain, and a confirmed 2cm parathyroid adenoma, with hypercalcemia (calcium level: 3.50 mmol/L) and no symptoms of polyuria, polydipsia, or central nervous system (CNS) involvement?
What is the most appropriate next step in managing a patient with primary hyperparathyroidism, presenting with fatigue, recurrent ureteric stones, bone pain, hypercalcemia (elevated calcium level), and a 2cm parathyroid adenoma?
What is the best treatment for a patient with a parathyroid adenoma, presenting with recurrent ureteric stones and body aches due to hypercalcemia?
What is metoprolol?
Is it safe for a pregnant individual to consume tuna and salmon, and what are the recommended weekly limits and preparation guidelines to avoid mercury exposure and food‑borne pathogens?
What is the most appropriate investigation for a 6‑month‑old infant after a single febrile urinary tract infection that has been treated with antibiotics?
A male newborn with cleft palate, micrognathia, glossoptosis, feeding difficulty, intermittent apnea, and partial nasogastric tube feeding—what is the most appropriate management?
Should a tiny femoral pseudoaneurysm identified nine days after cardiac catheterization lead to temporary activity restriction?
What is the appropriate urgent management for a patient with elevated troponin‑T, elevated CK‑MB, and markedly increased procalcitonin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.